For U.S. Audiences Only

including Patient Information for additional important safety information.

Image: Zokinvy (lonafarnib) logo

Now FDA Approved

for the treatment of Hutchinson-Gilford Progeria Syndrome (HGPS or Progeria) and processing-deficient Progeroid Laminopathies (PL).

Please see the full Prescribing Information for Zokinvy (lonafarnib).

Michiel, 21
Photos courtesy of The Progeria Research Foundation (with permission)
Meghan, 19
Average improvement in survival time in clinical trials with Zokinvy was 2.5 years; individual results may vary
Eiger OneCare

About Eiger ONECARE

Eiger OneCare provides personalized care and support for caregivers, families, and people taking Zokinvy.

Your specialized Zokinvy support team can help:

  • Investigate your insurance coverage
  • Assist with financial support options
  • Connect you to the Zokinvy pharmacy

Call 1 (833) MYEIGER

1 (833) 693–4437

Monday - Friday

9 AM ET - 5 PM ET

or fax 1 (888) 777-5680

Medical Information and Adverse Event Reporting:

1 (833) 267-0545*

Adverse Event Reporting:

1 (800) FDA-1088

*For Healthcare Professionals Only